VAS
AGN

Vestmark Advisory Solutions’s Allergan plc AGN Stock Holding History

Vestmark Advisory Solutions’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-13,354
Closed -$2.37M – 563
2020
Q1 		$2.37M Sell
13,354
-806
-6% -$152K 0.46% 48
2019
Q4 		$2.71M Sell
14,160
-1,923
-12% -$347K 0.56% 52
2019
Q3 		$2.71M Sell
16,083
-3,695
-19% -$602K 0.44% 53
2019
Q2 		$3.31M Buy
19,778
+122
+0.6% +$16.9K 0.57% 32
2019
Q1 		$2.88M Buy
+19,656
New +$2.85M 0.51% 40

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Vestmark Advisory Solutions's AGN Position: Q2 2020 in Review

Vestmark Advisory Solutions sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 13,354 shares — an estimated $2.37M sold.

Vestmark Advisory Solutions first reported a position in AGN in Q1 2019 and held it in 5 quarters. The position peaked at $3.31M in Q2 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Vestmark Advisory Solutions reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Vestmark Advisory Solutions sold 13,354 Allergan plc shares in Q2 2020, an estimated $2.37M.
  • Vestmark Advisory Solutions first reported a position in Allergan plc in Q1 2019 and held it in 5 quarters.
  • Vestmark Advisory Solutions's Allergan plc position peaked at $3.31M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2020, filed 13 Aug 2020.